Skip to main content

The first year of Cannabis Professional

Since launching a year ago, The Globe and Mail’s Cannabis Professional has become a leading source of business intelligence and breaking news for Canadians involved in the cannabis industry.

Please join Cannabis Professional to celebrate this milestone and connect with top executives in the cannabis sector at our one year anniversary event on September 24 at The Globe and Mail Centre in Toronto.

The evening also includes the opportunity to network with noted members of the industry and the editorial staff of Cannabis Professional. Food and refreshments will be provided.

Story continues below advertisement

Details:
  • Where: The Globe and Mail Centre, 16th floor, 351 King St. E., Toronto
  • When: Sept. 24, 2019
    • 5:30-6:15 pm: Arrival and networking
    • 6:15-6:30 pm: Opening remarks from Phillip Crawley
    • 6:30-7:00 pm: Panel discussion
    • 7:00-7:20pm pm: Fireside chat
    • 7:20 pm–onward: Networking

Legalization one year later

The event will feature a panel discussion of the state of Canada’s cannabis industry and how to drive further growth a year after the legalization of recreational usage. Confirmed panelists to date include Greg Engel, CEO of Organigram Inc., Rosy Mondin, CEO of World Class Extractions, Sherry Boodram, CEO of CannDelta, and John Fowler, founder of Supreme Cannabis.

Greg Engle, CEO of Organigram

Mr. Engel is a senior executive with 30 years of national and international experience in the pharmaceutical, biotechnology, cannabis and consumer packaged goods industries. Mr. Engel has led the creation, development and growth of several companies over the span of his career. An articulate and trusted voice in the burgeoning Canadian cannabis space, Mr. Engel most recently worked with a competitive licensed producer to become the first Canadian exporter of medical cannabis, as well as the establishment of several trailblazing industry standards. As leader at Organigram Inc, Mr. Engel is focused on reputational excellence through product quality and safety, expansion of the company’s Moncton, N.B. facility, and production efficiencies to position the company as a leader in the Medical and Adult Recreational Cannabis industries. Mr. Engel graduated from the University of Guelph with an Honours Bachelor of Science in Microbiology.

Rosy Mondin, CEO of World Class Extractions

With over 18 years of legal and entrepreneurial experience, Rosy Mondin has launched and managed public companies as well as start-ups. She has served as strategic advisor for companies involved in the processing, distribution, and safe use of medical cannabis. Ms. Mondin is the Co-founder & Executive Director at the Cannabis Trade Alliance of Canada and serves as Advisory Board Member for FinCanna Capital Corp and Special Advisor to the Association of Canadian Cannabis Retailers (ACCRES).

In 2014, Rosy co-founded Soma Labs Scientific which in 2016, amalgamated to form Quadron Cannatech Corporation. Quadron listed with the CSE in January 2017, making her the world’s first female founder and CEO of a publicly-traded cannabis company. In June 2019, Rosy became CEO of World Class Extractions after the recent merger with Quadron. She leads a diverse team of engineers, scientists and innovators to develop turn-key extraction and processing solutions for the cannabis industry.

In May 2018, Ms. Mondin presented to the Standing Senate Committee and provided valuable insight as to how Health Canada could benefit from implementing new regulations. Most recently, Ms. Mondin won the inaugural ‘Woman in Weed – Trailblazer’ Award at the 2018 Canadian Cannabis Awards and was featured in ‘Women in Weed’ and ‘The Growth Op’ as one of the most influential women in the cannabis space.

John Fowler, founder of Supreme Cannabis

John Fowler is Chief Advocacy Officer and Founder of The Supreme Cannabis Company, Inc. Mr. Fowler is a pioneer in the Canadian cannabis industry. He spent more than a decade in the medical cannabis sector as a cultivator, influencer, patients-rights advocate and lawyer.

In 2013, Mr. Fowler founded Supreme Cannabis’ wholly-owned subsidiary 7ACRES with a clear vision: to create Canada’s leading premium cannabis flower brand, and to produce high quality cannabis on a commercial scale. Today, 7ACRES is one of Canada’s leading premium flower brands. Prior to his work at Supreme Cannabis, Mr. Fowler was an associate at Torkin Manes LLP in Toronto, where he practiced corporate and securities law.

Story continues below advertisement

Mr. Fowler is also Vice Chair, Adult Use, and a Director of the Cannabis Council of Canada, the leading organization of Canada’s licensed producers of cannabis under Health Canada’s federal Cannabis Act.

Mr. Fowler graduated with distinction from the University of Toronto, with a Bachelor of Arts in political science and sociology. He also holds a Doctor of Law from the University of Ottawa, where he graduated Summa Cum Laude.

Sherry Boodram, CEO of CannDelta

Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., where she is responsible for providing regulatory expertise and developing strategies to ensure regulatory compliance within Canada’s existing cannabis framework.

Prior to founding CannDelta Inc., Sherry spent several years in the federal government, most notably Health Canada’s Medical Cannabis Program as a Senior Regulatory Compliance and Enforcement Officer where she was responsible for licensing application reviews and on-site facility inspections under the legislative regimes of the Marihuana for Medical Purposes Regulations (MMPR) and Access to Cannabis for Medical Purposes Regulations (ACMPR). She also contributed to field level input during the drafting of the current Cannabis Regulations.

As such, she has demonstrated in-depth knowledge and experience in the cannabis industry and has spoken at cannabis conferences in Canada and abroad.

Sherry holds a Ph.D. in Chemistry from York University, a Hon. B.Sc. from the University of Toronto, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College. She is also a member of the Canadian Association of Professionals in Regulatory Affairs (CAPRA).

Story continues below advertisement


Venture capital opportunitiesin the international cannabis space

Narbé Alexandrian

Narbé Alexandrian is the President and Chief Executive Officer of Canopy Rivers Inc., a venture capital firm specializing in cannabis. Prior to joining Canopy Rivers, Narbé was a Senior Associate at OMERS Ventures, one of the most prominent technology venture capital funds in Canada. During his tenure, Narbé helped fundraise for two funds ($520M of capital), sourced and lead multiple debt/equity financings, and acted as a Board Observer for a number of portfolio companies. Prior to OMERS Ventures, Narbé was a Senior Strategy Manager in TELUS’ Internet of Things (IoT) group where he helped launch operational go-to-market strategies to TELUS’ executive leadership team. He has also held roles at Firmex Inc., a leading virtual data room company based in Toronto, and Deloitte LLP, where he held roles in Financial Advisory and Consulting (fka Monitor Deloitte).


Please RSVP to this exclusive invitation by September 13

Cannabis Professional subscribers are invited to bring a colleague.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter